NAŘÍZENÍ KOMISE (XX) 2021/383
xx xxx 3.&xxxx;xxxxxx 2021,
xxxxxx xx xxxx xxxxxxx XXX nařízení Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) č. 1107/2009 uvedením xxxxxxx xxxxxxxxxxxx xxxxxx, xxxxx jsou xxxxxxxxxxxx xxxx xxxxxxx xxxxxxxxx xx xxxxxxx rostlin
(Text x&xxxx;xxxxxxxx xxx EHP)
EVROPSKÁ XXXXXX,
x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,
x&xxxx;xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1107/2009 xx dne 21.&xxxx;xxxxx&xxxx;2009 x&xxxx;xxxxxxx xxxxxxxxx xx ochranu xxxxxxx xx xxx x&xxxx;x&xxxx;xxxxxxx xxxxxxx Rady 79/117/EHS x&xxxx;91/414/XXX&xxxx;(1), x&xxxx;xxxxxxx xx xx.&xxxx;27 xxxx.&xxxx;2 x&xxxx;xx.&xxxx;78 xxxx.&xxxx;2 xxxxxxxxx xxxxxxxx
xxxxxxxx x&xxxx;xxxxx xxxxxxx:
|
(1) |
Xxxxxxxxxx přísady xxxx popsány x&xxxx;xx.&xxxx;2 xxxx.&xxxx;3 xxxx. x) xxxxxxxx (XX) č. 1107/2009 jako xxxxx xx xxxxxxxxx, xxxxx se xxxxxxxxx x&xxxx;xxxxxxxxxxx na xxxxxxx xxxxxxx xx v adjuvantech xxxx xxxx x&xxxx;xxxxxxxx xxxxxxx určeny, avšak xxxxx xxxxxxx xxxx xxxxxx látky, safenery xxx synergenty. |
|
(2) |
Formulační xxxxxxx xxxx nepřijatelné xxxx xxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxx, xxxxx xxxxxx xxxxxxx, xxxxx xxxxxxx po xxxxxxxx x&xxxx;xxxxxxx se xxxxxxxx xxxxx v ochraně xxxxxxx xxx zohlednění skutečných xxxxxxxx xxxxxxx, xxxx xxxxxxxx účinky xx xxxxxx xxxx xxxx xxxxxx anebo xx xxxxxxxx xxxx xx xxxxxxxxxxxx xxxxxx na xxxxxxx xxxxxxxxx. Xxxxxxxxxx xxxxxxx jsou xxxxxx xxxxxxxxxxxx xxxx xxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxx, xxxxx xxxxxx xxxxxxxxx po xxxxxxxx x&xxxx;xxxxxxx xx xxxxxxxx xxxxx x&xxxx;xxxxxxx xxxxxxx xxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxx xx xxxxxxxx xxxxxx xx xxxxxx xxxx xxxx xxxxxx xxxxx nepřijatelné xxxxxx xx xxxxxxxx, xxxxxxxxx xxxxxxxx xxxx xxxxxxx xxxxxxxxx. Xxxxxx xxxxxxxxxxxx formulační přísady xxxx xxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (ES) x.&xxxx;1107/2009. |
|
(3) |
Xxxxxxxxxx xxxxxxx xxxx xxxxx xxxx xxxxxxxxx xxxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxxx xx xxxxxxx xxxxxxx, x&xxxx;xxxx xxxxx xxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxxxx. Xxxxx xx xxxxxxxx xxxxxxxx xx xxxxxxxx xxxxxx, xxxxxxxxx xxxxxxxxx, xxxxxxxxxxx x&xxxx;xxxxxxxxxx vod xxxxxxxxx x&xxxx;xxxxxx 3.6.2, 3.6.3, 3.6.4, 3.6.5, 3.7, 3.8.2 a 3.10 xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1107/2009 měla xxx xxxxxx xxxxxxxxxx pro xxxxxxxxxxxx nepřijatelných xxxxxxxxxxxx xxxxxx. |
|
(4) |
Xxxxxx nepřijatelných xxxxxxxxxxxx xxxxxx xx xxx xxxxx xxxxxxxxx látky x&xxxx;xxxxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxxx, kategorie 1&xxxx;X&xxxx;xxxx 1X, jako xxxxxxxx, xxxxxxxxx 1&xxxx;X&xxxx;xxxx 1X, xxxx xxxx xxxxxxx xxx xxxxxxxxxx, kategorie 1&xxxx;X&xxxx;xxxx 1B, x&xxxx;xxxxxxx x&xxxx;xxxxxxxx VI xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008&xxxx;(2). |
|
(5) |
Xxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxx xx xxx xxxx zahrnovat xxxxx xxxxxxxxxxxxxx jako xxxxxxxxxxxx xxxxxxxxxxxxxxx x&xxxx;xxxxxxx („XXX“) nebo vysoce xxxxxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxxxxxxx („xXxX“) x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;57 xxxx. x) x&xxxx;x) xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1907/2006&xxxx;(3). |
|
(6) |
Xxxxxx xxxxxxxxxxxxxx formulačních xxxxxx xx měl rovněž xxxxxxxxx látky xxxxxxxxxx xxxxxxxxx xxxxx v důsledku xxxxxxxxxx xxxxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;57 písm. x) xxxxxxxx (XX) x.&xxxx;1907/2006 xxxx xxxxx xxxxxxxxxxxxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;528/2012&xxxx;(4) xxxx xxxxx xxxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxxxxx xxxxxxxxxxxx xxxxx („XXX“) xxxxx nařízení Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) 2019/1021&xxxx;(5). |
|
(7) |
Xxxxxxxx (ES) x.&xxxx;1907/2006 stanoví v příloze XXXX omezení xxx xxxxxxx nebezpečné xxxxx. Xxxxxxx-xx xxxxxxx xxxxxxxxx xxxxx xxxxxxx xxxxxxxxxxxx xxxxxx x&xxxx;xxxxxxxxxxx na xxxxxxx rostlin xxxxxxxx, xxxx xx xxx xxxxxxxx xx xxxxxx xxxxxxxxxxxx xxxxxx v příloze XXX nařízení (ES) x.&xxxx;1107/2009. |
|
(8) |
Xxxxxxx xxxxx xxxxxxxxxxxxxx xxxxxxxxxx přísady, xxxxx xxxxxxxx xx xxxxxxxxxxxx x&xxxx;xxxxxxxxxxx xx ochranu xxxxxxx xxxxxxxxxx xxxxx xxxxxxxx Rady 91/414/XXX&xxxx;(6) xxxx xxxxxxxx (ES) x.&xxxx;1107/2009. Takové formulační xxxxxxx xxxxxxxx Xxxxxxxx, Xxxxxx, Xxxxxxx, Německo, Xxxxxx, Xxxxx, Xxxxxxxxx x&xxxx;Xxxxxx. X&xxxx;xxxxxxxxx formulačních xxxxxx xx xxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxxxxx jako xxxxxxxxxxx, kategorie 1&xxxx;X&xxxx;xxxx 1X, xxxx xxxxxxxx, xxxxxxxxx 1 A nebo 1X, xxxx jako xxxxxxx xxx xxxxxxxxxx, xxxxxxxxx 1&xxxx;X&xxxx;xxxx 1X, x&xxxx;xxxxxxx x&xxxx;xxxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008, xxxxxxx xxxxxxxxxxxxxx xxxx XXX xxxx vPvB podle xx.&xxxx;57 xxxx. d) x&xxxx;x) xxxxxxxx (ES) x.&xxxx;1907/2006, přísady xxxxxxxxxxxxxx xxxx látky xxxxxxxxxx xxxxxxxxx obavy v důsledku xxxxxxxxxx vyvolávajících xxxxxxxx xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;57 xxxx. x) xxxxxxxx (XX) x.&xxxx;1907/2006 x&xxxx;xxxxxxx identifikované jako XXX podle xxxxxxxx (XX) 2019/1021 měly xxx xxxxxxx na xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (XX) x.&xxxx;1107/2009. |
|
(9) |
Xxxxxxx xxxxxxxxxxxxxx aminů xxxx (x.&xxxx;XXX 61791-26-2) x&xxxx;xxxxxxxxxxx xx xxxxxxx xxxxxxx xxxxxxxxxxxx xxxxxxxx bylo xxxxxxxx xxxxxxxxxx nařízením Xxxxxx (XX) 2016/1313&xxxx;(7), xxxxxxx xxxx xxxxxxxx xxxxx x&xxxx;xxxxxxxxxxx s toxicitou xxxxxxxxxxxxxx xxxxx xxxx x&xxxx;xxxxxx xxxxxxxxxxx xxx xxxxxxxxx xxxx xx xxxxxx xxxxxx. Vzhledem x&xxxx;xxxx, xx xxxxxxx xxxxx xxxxxxxxx z přirozených xxxxxxxxxx xxxxxxxxx xxxxx, x&xxxx;xx proto nejsou xxxxxxx xx xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx, xxx xxxx stejnou xxxxxxxx pro xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx, xxxx xx být ethoxylované xxxxx xxxx xxxxxx xxxxxxxx xx xxxxxx xxxxxxxxxxxx xxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (XX) x.&xxxx;1107/2009. |
|
(10) |
Xxxxxxxxxxx xxxxxxxxxxxx Komise (XX) 2016/109 (8) x&xxxx;(XX) 2018/619&xxxx;(9) nebyly xxxxxxxxx xxxxx XXXX (1600; 1.8), číslo XXX 27083-27-8 x&xxxx;32289-58-0, a PHMB (1415; 4.7), xxxxx XXX 32289-58-0 a 1802181-67-4, xxxx xxxxxxxxx xxxxxx xxxxx pro xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxxxx xxxx 6 (xxxxxxxxxxx xxx xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx), xxxx xxxxxx xxxx xxxxxxxxx v důsledku xxxxxxxxxxxxxx xxxxx pro lidské xxxxxx x&xxxx;xxxxxxx xxxxxxxxx. Xxxxxx xxxxxxx xxxx xxxxxxxxxxx pro xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxxx xx ochranu rostlin xx proto xxxxx x&xxxx;xxxxxxxxxxxxx xxxxxxx xx xxxxxx xxxxxx a životní xxxxxxxxx. Xxxxx by xxxxx PHMB (1600; 1.8) x&xxxx;XXXX (1415; 4.7) xxxx xxx xxxxxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (XX) x.&xxxx;1107/2009. |
|
(11) |
Xxxxxxxxxx xxxxxxx, xxxxx mají xxx xxxxxxx na xxxxxxx v příloze XXX xxxxxxxx (XX) x.&xxxx;1107/2009 xxxxx xxx rovněž xxxxxxxx v adjuvantech uváděných xx trh. Xxxxxxx xxxxx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxx xxx xxxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;58 xxxx.&xxxx;2 nařízení (XX) x.&xxxx;1107/2009, mohou xxxxxxx xxxxx nadále xxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx xx adjuvantů, xxxxx xxxx v souladu x&xxxx;xx.&xxxx;81 odst. 3 xxxxxxxxx xxxxxxxx. Xxxxxxx xxxxxxxx (XX) x.&xxxx;1107/2009 xx xx xxx zabránit xxxxxxx xx trh xxxx používání xxxxxxxxx xxxxxxxxxxxx zakázané formulační xxxxxxx, xx potřeba xxxxxxxx, xxx xxxxxx xxxxxxxxx, které xxxx xxx smíseny s přípravky xx xxxxxxx xxxxxxx, xxxxxxxxxxxx xxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxx. |
|
(12) |
Xxxxxxxx xxxxxx by xxx xxx xxxxxxxxx dostatek xxxx xx xxxxxxx xxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxx x&xxxx;xxxxxxxxx, xxxxx jsou v současnosti xxxxxxxx na jejich xxxxx, xxx xxxxx xxxxxxxx, xxx xxxxxxxx xxxxxxxxxx přísady uvedené xx seznamu v příloze XXX nařízení (ES) x.&xxxx;1107/2009, a aby xxxxx xxxxxxxx nebo změnit xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxx a adjuvantů xxxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxxxx. |
|
(13) |
X&xxxx;xxxxxxxxx na xxxxxxx xxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx formulační xxxxxxx xxxxxxxx xx xxxxxxx x&xxxx;xxxxxxx III xxxxxxxx (XX) x.&xxxx;1107/2009, xxx xxx členské xxxxx xxxxx xxxxxxxxxx xxxxxxxxx xxxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;46 xxxxxxxxx xxxxxxxx xxxx xxxxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxx xxxxxxxxxx xxxxxxxxx, xx xxxxxxx xxxxx xxxx uplynout xxx prodej a distribuci xxxxxxxxxx xx xxx xxxxxx x&xxxx;xxx odstranění, xxxxxxxxxx a využití xx xxxxxxx xxxxx měsíců xx xxxx změny xxxx xxxxxx xxxxxxxx. |
|
(14) |
Xxxxxxxxxx xxxxxxx, které xxxx xxx xxxxxxx xx xxxxxxx v příloze XXX xxxxxxxx (XX) x.&xxxx;1107/2009, xxxxx xxx přítomny xxxx xxxxxxxxx nečistoty x&xxxx;xxxxxx xxxxxxxxxxxx přísadách, xxxxx xxxx xxxx xxxxxx xxxxxxxxxx xxx xxxxxxx x&xxxx;xxxxxxxxxxx xx xxxxxxx xxxxxxx nebo xxxxxxxxxxx. Xxxxx xx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxxxx na xxxxxxx xxxxxxx xxxx adjuvantu xxxx xxx nižší xxx 0,1&xxxx;% xxxxxxxxxxxx (xxxx.) xxxx xxxxx xxx xxxxxxxxxx koncentrační xxxxx xxxxxxxx se XXX xxxxxxxxxx (xxxxxxxxxxxxxx, xxxxxxxxxxx x&xxxx;xxxxxxxxx xxx xxxxxxxxxx), xx-xx xxxxxxxx x&xxxx;xxxxxxx XX xxxxxxxx (XX) č. 1272/2008 pro xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx xx xxxxxx nižší xxx 0,1 % xxxxxxxxxxxx (xxxx.), xxx bylo xxxxx xx považovat xx xxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxx není x&xxxx;xxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxxxxx metod xxxxxxxx xxxx xxxxx. |
|
(15) |
Xxxxxxxx xxxxxxxxx xxxxx nařízením xxxx x&xxxx;xxxxxxx xx xxxxxxxxxxx Xxxxxxx xxxxxx xxx rostliny, xxxxxxx, xxxxxxxxx a krmiva, |
PŘIJALA TOTO XXXXXXXX:
Článek 1
Příloha XXX nařízení (XX) x.&xxxx;1107/2009 se xxxx v souladu x&xxxx;xxxxxxxx xxxxxx xxxxxxxx.
Článek 2
Členské xxxxx, které xxxxxxx xxxxxxxx pro xxxxxxxxx xx xxxxxxx xxxxxxx obsahující formulační xxxxxxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (XX) x.&xxxx;1107/2009, xx xxxxx tohoto xxxxxxxx, xxxxxxx xxxxxxxx xxxxx xxxx xxxxxxx xx xxxxxxxx, xxxxx xxxxxxxxxx xx 24.&xxxx;xxxxxx 2023.
Xxxxxx&xxxx;3
Xxxxxxx xxxxx xxxxxxxx xxxxxxx xx xxx xxxx používání adjuvantů xxxxxxxxxxxx formulační xxxxxxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX nařízení (XX) x.&xxxx;1107/2009, xx xxxxx xxxxxx nařízení.
Členské xxxxx, xxxxx xxxxxxxx xxxxxxxxx obsahující xxxxxxxxxx xxxxxxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (XX) x.&xxxx;1107/2009, xx znění xxxxxx xxxxxxxx, xxxxxxx povolení xxxxx nebo odejmou xx nejdříve, xxxxx xxxxxxxxxx do 24.&xxxx;xxxxxx 2023.
Článek 4
Jakákoliv odkladná xxxxx xxxxxxx xxxxxxxxx xxxxx x&xxxx;xxxxxxx s článkem 46 nařízení (XX) x.&xxxx;1107/2009 xxxx xxxxxxxxxxxxxx xxxxxxxx xxx xxxxxxxxxx xxxxxxxxx xxxx xxx xx xxxxxxxxx x&xxxx;xxxx xxxxxxxx pro xxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxxx xx tři xxxxxx x&xxxx;xxx xxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxx xx dalších xxxxx xxxxxx xx xxxx xxxxx xxxx xxxxxx povolení uvedených x&xxxx;xxxxxxxx 2 a 3.
Xxxxxx&xxxx;5
Xxxx xxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx dvacátým xxxx xx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.
Toto xxxxxxxx je xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx xxxxxxxxxx ve xxxxx členských státech.
V Bruselu xxx 3. března 2021.
Za Xxxxxx
xxxxxxxxxxx
Xxxxxx VON XXX XXXXX
(1)&xxxx;&xxxx;Xx. věst. X&xxxx;309, 24.11.2009, x.&xxxx;1.
(2)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 ze xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) x.&xxxx;1907/2006 (Xx. xxxx. X&xxxx;353, 31.12.2008, x.&xxxx;1).
(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1907/2006 ze dne 18.&xxxx;xxxxxxxx&xxxx;2006 o registraci, xxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx xxxxx, o zřízení Evropské xxxxxxxx xxx xxxxxxxx xxxxx, x&xxxx;xxxxx xxxxxxxx 1999/45/XX a o zrušení nařízení Xxxx (EHS) x.&xxxx;793/93, xxxxxxxx Xxxxxx (XX) x.&xxxx;1488/94, xxxxxxxx Xxxx 76/769/XXX a směrnic Xxxxxx 91/155/XXX, 93/67/XXX, 93/105/ES x&xxxx;2000/21/XX (Úř. xxxx. X&xxxx;396, 30.12.2006, x.&xxxx;1).
(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) č. 528/2012 xx xxx 22.&xxxx;xxxxxx&xxxx;2012 x&xxxx;xxxxxxxx xxxxxxxxxx xxxxxxxxx xx xxx x&xxxx;xxxxxx xxxxxxxxx (Xx. věst. X&xxxx;167, 27.6.2012, x.&xxxx;1).
(5)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) 2019/1021 ze xxx 20.&xxxx;xxxxxx&xxxx;2019 x&xxxx;xxxxxxxxxxxxxx organických xxxxxxxxxxxxxx látkách (Xx. xxxx. X&xxxx;169, 25.6.2019, x.&xxxx;45).
(6)&xxxx;&xxxx;Xxxxxxxx Xxxx 91/414/EHS xx xxx 15.&xxxx;xxxxxxxx&xxxx;1991 x&xxxx;xxxxxxx přípravků xx xxxxxxx rostlin na xxx (Xx. věst. X&xxxx;230, 19.8.1991, x.&xxxx;1).
(7)&xxxx;&xxxx;Xxxxxxxxx xxxxxxxx Komise (EU) 2016/1313 xx xxx 1.&xxxx;xxxxx&xxxx;2016, kterým se xxxx xxxxxxxxx xxxxxxxx (XX) x.&xxxx;540/2011, xxxxx xxx x&xxxx;xxxxxxxx schválení xxxxxx xxxxx glyfosátu (Xx. xxxx. X&xxxx;208, 2.8.2016, x.&xxxx;1).
(8)&xxxx;&xxxx;Xxxxxxxxx xxxxxxxxxx Xxxxxx (XX) 2016/109 xx dne 27. ledna 2016 x&xxxx;xxxxxxxxxxx XXXX (1600; 1.8) xxxx xxxxxxxxx xxxxxx xxxxx pro xxxxxxx v biocidních xxxxxxxxxxx xxxxxxxx xxx xxxx xxxxxxxxx 1, 6 x&xxxx;9 (Úř. xxxx. X&xxxx;21, 28.1.2016, s. 84).
(9) Prováděcí xxxxxxxxxx Xxxxxx (XX) 2018/619 ze dne 20.&xxxx;xxxxx&xxxx;2018 x&xxxx;xxxxxxxxxxx XXXX (1415; 4.7) xxxx xxxxxxxxx účinné xxxxx xxx použití x&xxxx;xxxxxxxxxx xxxxxxxxxxx xxxx 1, 5 a 6 (Xx. xxxx. X&xxxx;102, 23.4.2018, x.&xxxx;21).
PŘÍLOHA
Příloha XXX nařízení (XX) x.&xxxx;1107/2009 se xxxxxxxxx xxxxx:
„XXXXXXX XXX
Xxxxxx xxxxxxxxxxxx přísad, které xxxx nepřijatelné xxxx xxxxxxx přípravků xx xxxxxxx xxxxxxx, xxxxxxx x&xxxx;xxxxxx&xxxx;27&xxxx;&xxxx;(1)
|
X. |
Xxxxx |
Xxxxx ES/jiné názvy |
Číslo XXX |
Xxxxx ES |
Klasifikace/jiné xxxxxxxxxx |
|
1. |
1-xxxxx-2,3-xxxxxxxxxxx |
xxxxxxxxxxxxxx; 2,3-xxxxxxxxxxx-xxxxxxx |
106-89-8 |
203-439-8 |
xxxxxxxxxxxx xxx. 1X |
|
2. |
1,2-xxxxxxxxxxxx |
1,2-xxxxxxxxxxxx; xxxxx, 1,2-xxxxxxx- |
107-06-2 |
203-458-1 |
xxxxxxxxxxxx kat. 1X |
|
3. |
2-xxxxxxxxxxxxx |
2-xxxxxxxxxxxxx; xxxxxxx, 2-xxxxxx- |
110-80-5 |
203-804-1 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
|
4. |
2-xxxxxxxxxxx-xxxxxx |
2-xxxxxxxxxxxxx-xxxxxx; xxxxxxx, 2-xxxxxx-, 1-xxxxxx |
111-15-9 |
203-839-2 |
xxxxxxx pro xxxxxxxxxx kat. 1B |
|
5. |
1-ethylpyrrolidin-2-on |
1-ethylpyrrolidin-2-on; N-ethyl-2-pyrrolidon |
2687-91-4 |
220-250-6 |
toxické xxx reprodukci kat. 1X |
|
6. |
2-xxxxxxxxxxxxxx |
2-xxxxxxxxxxxxxx; xxxxxxx, 2-xxxxxxx- |
109-86-4 |
203-713-7 |
xxxxxxx xxx xxxxxxxxxx kat. 1X |
|
7. |
2-xxxxxxxxxxxx-xxxxxx |
2-xxxxxxxxxxxx-xxxxxx; xxxxxxx, 2-xxxxxxx-, 1-xxxxxx; 2-xxxxxxxxxxxxxx-xxxxxx |
110-49-6 |
203-772-9 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
|
8. |
2-xxxxxxxxxxxxx-1-xx |
2-xxxxxxxxxxxxx-1-xx; 1-xxxxxxxx, 2-xxxxxxx- |
1589-47-5 |
216-455-5 |
xxxxxxx pro xxxxxxxxxx xxx. 1X |
|
9. |
1-xxxxxxxxxxxxxxxx-2-xx |
1-xxxxxx-2-xxxxxxxxxx; 2-xxxxxxxxxxxx, 1-xxxxxx- |
872-50-4 |
212-828-1 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
|
10. |
2-xxxxxxxxxxx |
2-xxxxxxxxxxx; xxxxxx, 2-xxxxx- |
79-46-9 |
201-209-1 |
xxxxxxxxxxxx xxx. 1X |
|
11. |
xxxxxxxxxx loje, ethoxylované |
alkylaminy xxxx, ethoxylované; ethoxylovaný xxxx xxxx |
61791-26-2 |
xxxxx nebo xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxx na lidské xxxxxx nebo životní xxxxxxxxx |
|
|
12. |
xxxxxxxxxx xxxx, ethoxylované x&xxxx;xxxxxxxxxxxxx |
xxxxxxxxxx loje, xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx; xxxxxxxxxxxx a propoxylovaný xxxx xxxx |
68213-26-3 |
xxxxx xxxx chybějící xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxx xx xxxxxx xxxxxx nebo xxxxxxx xxxxxxxxx |
|
|
13. |
xxxxxxxxx xxxxxx |
xxxxxxxxxxxx azbest; azbest, xxxxxxxxxxxx |
77536-66-4 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
|
|
14. |
xxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxx |
12172-73-5 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
||
|
15. |
xxxxxxxxxxxx xxxxxx; xxxxxx, antofylitový |
77536-67-5 |
karcinogenní xxx. 1 A |
||
|
16. |
chrysotilový xxxxxx; xxxxxx, xxxxxxxxxxxx |
12001-29-5 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
||
|
17. |
xxxxxxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxxxxxx |
12001-28-4 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
||
|
18. |
xxxxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxxxx |
77536-68-6 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
||
|
19. |
xxxxxx |
xxxxxx |
71-43-2 |
200-753-7 |
xxxxxxxxxxxx kat. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
20. |
xxxxx[xxx]xxxxxxx&xxxx;&xxxx;(2); xxxxx[xxx]xxxxxxxx |
xxxxx[xxx]xxxxxxx; xxxxx[x]xxxxx |
50-32-8 |
200-028-5 |
xxxxxxxxxxxx xxx. 1X/xxxxxxxxx xxx. 1X/ xxxxxxx xxx xxxxxxxxxx xxx. 1X |
|
21. |
xxx(2-xxxxxxxxxxxx)xxxxxx-1,2-xxxxxxxxxxxx |
xxxxxxxxxx-xxxxxx |
84-69-5 |
201-553-2 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxx xxxxxx), xxxxxxx xxx xxxxxxxxxx xxx. 1X |
|
22. |
xxxxxxxx xxxxxx |
xxxxxxxx xxxxxx |
10043-35-3 11113-50-1 |
233-139-2 234-343-4 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
|
23. |
xxxxxxxxxxx disodný |
oktaboritan disodný; xxxxxxxxxxx xxxxxxx, xxxxxxx |
12008-41-2 |
234-541-0 |
xxxxxxx xxx reprodukci xxx. 1X |
|
24. |
xxxxxxxxxxx xxxxxxx, tetrahydrát |
kyselina xxxxxx, disodná xxx, xxxxxxxxxxx |
12280-03-4 |
234-541-0 |
xxxxxxx pro xxxxxxxxxx xxx. 1X |
|
25. |
xxxxxxxxxxxx xxxxxxx, xxxxxxx |
xxxxxxxxxxxx disodný, xxxxxxx; xxxxx-xxxxxxx-xxxx |
1330-43-4 |
215-540-4 |
xxxxxxx xxx reprodukci xxx. 1X |
|
26. |
xxxxxxxxxxxx xxxxxxx, dekahydrát |
borax |
1303-96-4 |
215-540-4 |
toxické xxx reprodukci kat. 1X |
|
27. |
xxxxxxxxxxxx xxxxxxx, xxxxxxxxxxx |
xxxxx-xxxxxxx-xxxx, xxxxxxxxxxx |
12179-04-3 |
215-540-4 |
xxxxxxx xxx reprodukci xxx. 1X |
|
28. |
xxxxxxxx xxxxxxxxxxx, xxxxx xxx |
xxxxxxxx xxxxxxxxxxx, xxxxx xxx; xxxxxxxx xxxxxx, xxxxx xxx |
13840-56-7 |
237-560-2 |
xxxxxxx xxx reprodukci xxx. 1X |
|
29. |
xxxxxxxxxxxx disodný, xxxxxxxxxx |
xxxxxxxxxxxx xxxxxxx, monohydrát; borum-natrium-oxid, monohydrát |
12267-73-1 |
235-541-3 |
toxické xxx xxxxxxxxxx xxx. 1X |
|
30. |
xxxx-1,3-xxxx |
xxxx-1,3-xxxx; 1,3-xxxxxxxx |
106-99-0 |
203-450-8 |
xxxxxxxxxxxx xxx. 1 A/ mutagenní xxx. 1B |
|
31. |
butan obsahující ≥&xxxx;0,1&xxxx;% xxxxxxxxx (x.&xxxx;XX 203-450-8) |
butan |
106-97-8 |
203-448-7 |
karcinogenní xxx. 1&xxxx;X |
|
32. |
xxxxxx(xxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxx-xxxxxxxxxxxx), (xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxx-xxxxxxxxxxxx) |
xxxxxxxx, X,X“’-1,6-xxxxxxxxxxxx[X’-xxxxx-, xxxxxxx s 1,6-hexandiaminem, hydrochlorid; poly[iminokarbonimidoyliminokarbonimidoylimino-1,6-hexandiyl], xxxxxxxxxxxx; xxxxxxxx, X-xxxxx-, xxxxx. x&xxxx;1,6-xxxxxxxxxxxxx (2:1), xxxxxxx x&xxxx;1,6-xxxxxxxxxxxxx, hydrochlorid (1:2); XXXX |
27083-27-8 x 32289-58-0 x 1802181-67-4 |
xxxxxxxxxxx xxx použití x&xxxx;xxxxxxxxxx xxxxxxxxxxx typu 6 (xxxxxxxxxxx xxx výrobky x&xxxx;xxxxxxxxxx xxxxxxx) |
|
|
33. |
xxxxxxx-xxxxxx |
x-xxxxx-xxxxxx; xxxxxxx-xxxxxx-1,2-xxxxxxxxxxxx |
84-74-2 |
201-557-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx REACH – xxxxxx xxxxxx), toxické xxx xxxxxxxxxx xxx. 1X |
|
34. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx naftenické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx do xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
64742-52-5 |
265-155-0 |
karcinogenní xxx. 1X |
|
|
35. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx do dimethylsulfoxidu (XXXX) (stanovení postupem XX 346) |
64742-54-7 |
265-157-1 |
xxxxxxxxxxxx kat. 1X |
|
|
36. |
xxxxxxxxx (ropné), xxxxxxxxxxxxx xxxxx xxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (stanovení xxxxxxxx XX 346) |
64742-53-6 |
265-156-6 |
xxxxxxxxxxxx xxx. 1X |
|
|
37. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx xxxxxxxxxxx s obsahem ≥&xxxx;3,0&xxxx;% hmotnostních látek xxxxxxxxxxxxxxxx do dimethylsulfoxidu (XXXX) (xxxxxxxxx postupem XX 346) |
64742-55-8 |
265-158-7 |
xxxxxxxxxxxx xxx. 1X |
|
|
38. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx parafinické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx do xxxxxxxxxxxxxxxxx (DMSO) (xxxxxxxxx xxxxxxxx XX 346) |
64742-65-0 |
265-169-7 |
xxxxxxxxxxxx xxx. 1X |
|
|
39. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxxx s obsahem ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx látek xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
64741-88-4 |
265-090-8 |
xxxxxxxxxxxx xxx. 1B |
|
|
40. |
destiláty (xxxxx), xxxxxxxxxxxxxx rafinované xxxxx parafinické s obsahem ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx látek xxxxxxxxxxxxxxxx do xxxxxxxxxxxxxxxxx (XXXX) (stanovení xxxxxxxx XX 346) |
64741-89-5 |
265-091-3 |
xxxxxxxxxxxx kat. 1X |
|
|
41. |
xxxxxxxxxxx |
xxxxxxxxxxx; xxxxxx; epoxyethan |
75-21-8 |
200-849-9 |
karcinogenní xxx. 1X/ xxxxxxxxx kat. 1X |
|
42. |
xxxxxxxxxxx |
xxxxxxxxxxx; formalin; xxxxxxxx; xxxxxx |
50-00-0 |
200-001-8 |
xxxxxxxxxxxx xxx. 1X |
|
43. |
xxxxxxxx |
xxxxxxxx; xxxxxxxxxx |
75-12-7 |
200-842-0 |
xxxxxxx pro xxxxxxxxxx xxx. 1X |
|
44. |
xxxxxxxx (obsahující ≥&xxxx;0,1&xxxx;% xxxxxxxxx (x.&xxxx;XX 203-450-8)) |
xxxxxxxx; propan, 2-methyl- |
75-28-5 |
200-857-2 |
karcinogenní xxx. 1 A/ mutagenní kat. 1X |
|
45. |
xxxxxx oleje (xxxxx), X20–50, xxxxxxxxxxxxx xxxxxxxxx xxxxx, xxxxxxxxxxxxxx s obsahem ≥&xxxx;3,0&xxxx;% hmotnostních látek xxxxxxxxxxxxxxxx xx dimethylsulfoxidu (XXXX) (xxxxxxxxx postupem XX 346) |
72623-85-9 |
276-736-3 |
xxxxxxxxxxxx xxx. 1X |
|
|
46. |
xxxxxx oleje (ropné), X15–30, xxxxxxxxxxxxx neutrální xxxxx, x&xxxx;xxxxxxx ≥ 3,0 % xxxxxxxxxxxx látek xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (DMSO) (xxxxxxxxx xxxxxxxx XX 346) |
72623-86-0 |
276-737-9 |
xxxxxxxxxxxx xxx. 1X |
|
|
47. |
xxxxxx xxxxx (xxxxx), X20–50, xxxxxxxxxxxxx neutrální ropné, x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx extrahovatelných xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
72623-87-1 |
276-738-4 |
karcinogenní xxx. 1X |
|
|
48. |
xxxxxx xxxxx (xxxxx), X17–32, rozpouštědlově xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxxxx, x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx extrahovatelných do xxxxxxxxxxxxxxxxx (XXXX) (stanovení xxxxxxxx XX 346) |
101316-70-5 |
309-875-6 |
xxxxxxxxxxxx xxx. 1X |
|
|
49. |
xxxxxxxxx xxxxxx (xxxxx), xxxxx alkylát, xxxxxxxx rozvětvený řetězec X9–X12, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7) |
64741-65-7 |
265-067-2 |
karcinogenní xxx. 1B/ mutagenní kat. 1X |
|
|
50. |
xxxxxxxxx xxxxxx (ropná), xxxxxxxxxxxx xxxxxxxx těžká, xxxxxxxx X7–X12, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7) |
64742-82-1 |
265-185-4 |
xxxxxxxxxxxx xxx. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
|
51. |
xxxxxxxxx frakce (xxxxx), hydrogenačně xxxxxxxx xxxxx, xxxxxxxxxxxxxxx, převážně x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxxx C7, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7) |
92045-53-9 |
295-434-2 |
xxxxxxxxxxxx xxx. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
|
52. |
xxxxxxxxx xxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx, xxxxxxxx X6–X13, x&xxxx;xxxxxxx ≥ 0,1 % xxxxxxx (x.&xxxx;XX 200-753-7) |
64742-48-9 |
265-150-3 |
xxxxxxxxxxxx kat. 1&xxxx;X/ xxxxxxxxx kat. 1X |
|
|
53. |
xxxxxxxxx xxxxxx (xxxxx), lehká xxxxxxxxxx, xxxxxxxx X8–X10, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7) |
64742-95-6 |
265-199-0 |
karcinogenní xxx. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
|
54. |
xxxxxxxxxxx |
xxxxxxxxxxx; xxxxxx, xxxxx- |
98-95-3 |
202-716-0 |
xxxxxxx xxx reprodukci xxx. 1X |
|
55. |
X-xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx; xxxxxxxx, X-xxxxxx- |
123-39-7 |
204-624-6 |
xxxxxxx xxx xxxxxxxxxx xxx. 1B |
|
56. |
nonylfenoly: látky x&xxxx;xxxxxxxxx x/xxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 9 xxxxxx xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx na xxxxxxxxx xxxxxx, zahrnující xxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxxx z individuálních xxxxxxx xxxx xxxxxx xxxxxxxxx |
4-(3,5-xxxxxxxxxxxxxx-3-xx)xxxxx; xxxxx, 4-(1-xxxxx-1,3-xxxxxxxxxxxxxx)-; 4-(1-xxxxx-1,3-xxxxxxxxxxxxxx)xxxxx |
186825-36-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
57. |
4-(3,6-xxxxxxxxxxxxxx-3-xx)xxxxx; xxxxx, 4-(1-xxxxx-1,4-xxxxxxxxxxxxxx)-; 4-(1-xxxxx-1,4-xxxxxxxxxxxxxx)xxxxx |
142731-63-3 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
58. |
4-(2-xxxxxxxxxxx-2-xx)xxxxx; x-(1,1-xxxxxxxxxxxxxx)xxxxx; xxxxx, 4-(1,1-dimethylheptyl)- |
30784-30-6 |
250-339-5 |
vlastnosti xxxxxxxxxxxx narušení endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
|
|
59. |
4-(3-methyloktan-3-yl)fenol; fenol, 4-(1-xxxxx-1-xxxxxxxxxxx)-; 4-(1-xxxxx-1-xxxxxxxxxxx)xxxxx |
52427-13-1 |
257-907-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
|
|
60. |
4-xxxxxxxxxx x-xxxxxxxxxx; xxxxx, 4-nonyl- |
104-40-5 |
203-199-4 |
vlastnosti vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
61. |
xxxxxxxxxxxxx |
11066-49-2 |
234-284-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
|
62. |
x-xxxxxxxxxxxxx; xxxxx, 4-xxxxxxxx- |
26543-97-5 |
247-770-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
|
63. |
xxxxxxxxxx; xxxxx, xxxxx- |
25154-52-3 |
246-672-0 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
64. |
xxxxx, 4-(1-xxxxxxxxxxx)-; x-(1-xxxxxxxxxxx)xxxxx |
17404-66-9 |
241-427-4 |
xxxxxxxxxx vyvolávající xxxxxxxx endokrinní činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
|
65. |
xxxxx, 4-xxxxx-, xxxxxxxxxx |
84852-15-3 |
284-325-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
66. |
xxxxx, xxxxx-, rozvětvený |
90481-04-2 |
291-844-0 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
67. |
xxxxxxxxxxx, xxxxxxxxxxxx: xxxxx s lineárním x/xxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 9 xxxxxx xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx xx xxxxxxxxx xxxxxx, xxxxxxxxxxxx, zahrnující xxxxxx xxxxx, které xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx jejich xxxxxxxxx |
xxxxxxxxxx, xxxxxxxxxxxx; xxxx(xxx-1,2-xxxxxxxxx), α-(xxxxxxxxxx)-ω-xxxxxxx- |
500-024-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
|
68. |
4-xxxxxxxxxx, rozvětvený, xxxxxxxxxxxx, 1–2,5 xxx; xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx-, rozvětvený |
500-315-8 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
69. |
4-xxxxxxxxxx, xxxxxxxxxxxx, 1–2,5 mol |
500-045-0 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
70. |
2-(2-{2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx}xxxxxx)xxxxx-1-xx; 2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]xxxxxxx; xxxxxxx, 2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]- |
7311-27-5 |
230-770-5 |
xxxxxxxxxx xxxxxxxxxxxx narušení endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
71. |
2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxxx; xxxxxxx, 2-[2-(4-xxxxxxxxxxx)xxxxxx]- |
20427-84-3 |
243-816-4 |
xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx) |
|
|
72. |
20-(4-xxxxxxxxxxx)-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx; 3,6,9,12,15,18-xxxxxxxxxxxxxx-1-xx, 20-(4-xxxxxxxxxxx)- |
27942-27-4 |
248-743-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
|
73. |
2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]xxxxx-1-xx; xxxxxxx, 2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]- |
7311-27-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
74. |
26-(4-xxxxxxxxxxx)-3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx; 3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-(4-xxxxxxxxxxx)- |
14409-72-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
|
75. |
17-(4-xxxxxxxxxxx)-3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx; 3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx, 17-(4-xxxxxxxxxxx)- |
34166-38-6 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
76. |
xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx-, xxxxxxxxxx |
127087-87-0 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) nařízení XXXXX – životní xxxxxxxxx) |
||
|
77. |
xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx- |
26027-38-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
78. |
xxxxxxx, 2-(4-xxxxxxxxxxx)- |
104-35-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
|
79. |
xxxxxxxxxxxxx, xxxxxxxxxxxx; xxxx(xxx-1,2-xxxxxxxxx), α-(xxxxxxxxxxxxx)-ω-xxxxxxx- |
37205-87-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
|
80. |
2-[2-(4-xxxx-xxxxxxxxxxx)xxxxxx]xxxxxxx; xxxxxxx, 2-[2-(4-xxxx-xxxxxxxxxxx)xxxxxx]- |
156609-10-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 písm. x) xxxxxxxx XXXXX – životní prostředí) |
||
|
81. |
poly(oxy-1,2-ethandiyl), α-(xxxxxxxxxx)-ω-xxxxxxx- xxxxxxxxxx, ethoxylovaný |
9016-45-9 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
82. |
xxxxxxxxxxx: xxxxx s lineárním x/xxxx xxxxxxxxxxx alkylovým xxxxxxxx s počtem 8 xxxxxx xxxxxxxxxx vázaných x&xxxx;xxxxxxx na xxxxxxxxx xxxxxx, xxxxxxxxxx rovněž xxxxx, xxxxx xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx jejich xxxxxxxxx |
x-xxxxxxxxxx; 4-xxxxxxxxxx |
1806-26-4 |
217-302-5 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – životní xxxxxxxxx) |
|
83. |
4-(2,4,4-xxxxxxxxxxxxxxx-2-xx)xxxxx; 4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx; 4-(xxxx-xxxxx)xxxxx; xxxxx, 4-(1,1,3,3-xxxxxxxxxxxxxxxx)-; 4-xxxx-xxxxxxxxxx |
140-66-9 |
205-426-2 |
xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. f) nařízení XXXXX – životní xxxxxxxxx) |
|
|
84. |
xxxxxxxxxx; xxxxx, oktyl- |
67554-50-1 |
266-717-8 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx prostředí) |
|
|
85. |
fenol, 2-xxxxxxxx- |
86378-08-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní prostředí) |
||
|
86. |
fenol, xxxxxxxx-; xxxxxxxxxxxxx |
11081-15-5 |
234-304-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
|
|
87. |
xxxxx, 2-xxxxx-; x-xxxxxxxxxx |
949-13-3 |
213-437-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx prostředí) |
|
|
88. |
fenol, 2-xxx-xxxxx-; x-xxx-xxxxxxxxxx |
26401-75-2 |
247-663-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – životní prostředí) |
|
|
89. |
fenol, 4-xxxxxxxx-; x-xxxxxxxxxxxxx |
27013-89-4 |
248-164-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
90. |
xxxxx, 4-xxx-xxxxx-; x-xxx-xxxxxxxxxx |
27214-47-7 |
248-330-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
91. |
xxxxx, xxx-xxxxx-; xxx-xxxxxxxxxx |
93891-78-2 |
299-461-0 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx prostředí) |
|
|
92. |
fenol, 4-(1-xxxxxxxxxx)-; x-(1-xxxxxxxxxx)xxxxx |
3307-00-4 |
221-989-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
|
|
93. |
xxxxx, 2-(1-xxxxxxxxxxxxxx)-; x-(1-xxxxxxxxxxxx)xxxxx |
18626-98-7 |
242-459-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
94. |
xxxxx, 2-(1-xxxxxxxxxx)-; x-(1-xxxxxxxxxx)xxxxx |
17404-44-3 |
241-426-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
|
|
95. |
fenol, 2-(1-xxxxxxxxxxxx)-; x-(1-xxxxxxxxxxxx)xxxxx |
37631-10-0 |
253-574-1 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx) |
|
|
96. |
xxxxx, 4-(1-propylpentyl)-; p-(1-propylpentyl)fenol |
3307-01-5 |
221-990-2 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. f) xxxxxxxx REACH – xxxxxxx prostředí) |
|
|
97. |
fenol, 2-(1-xxxxxxxxxxxx)-; x-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx |
3884-95-5 |
223-420-8 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) nařízení REACH – životní xxxxxxxxx) |
|
|
98. |
xxxxx, (1,1,3,3-xxxxxxxxxxxxxxxx)-; (1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx |
27193-28-8 |
248-310-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
99. |
xxxxx, (1-xxxxxxxxxxxx)-; (1-xxxxxxxxxxxx)xxxxx |
27985-70-2 |
248-759-9 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
|
|
100. |
fenol, 4-(2-methylheptyl)- |
898546-19-5 |
vlastnosti xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
101. |
xxxxx, 2-(2-xxxxxxxxxx)- |
28752-62-7 |
xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
|
102. |
xxxxx, 4-(1-xxxxxxxxxxxx)-; x-(1-xxxxxxxxxxxx)xxxxx |
1818-08-2 |
217-332-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
103. |
xxxxx, 4-(2-xxxxxxxxxx)- |
69468-20-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
|
104. |
fenol, 4-(5-xxxxxxxxxxxx)- |
1824164-95-5 |
xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
105. |
xxxxx, 2-(2-methylheptyl)- |
898546-20-8 |
vlastnosti vyvolávající xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
106. |
xxxxx, 4-(2-xxxxxxxxxxxx)- |
119747-99-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (čl. 57 písm. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
|
107. |
fenol, 3-xxxxx- |
20056-69-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
|
108. |
xxxxx, 2-(1,1-xxxxxxxxxxxxx)- |
1824575-79-2 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
|
109. |
xxxxx, 4-(1,1-xxxxxxxxxxxxx)- |
30784-29-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
|
110. |
xxxxx, 4-(5,5-xxxxxxxxxxxxx)- |
13330-52-4 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
111. |
xxxxx, 2-(5,5-xxxxxxxxxxxxx)- |
1822989-97-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
|
112. |
xxxxx, 3-(1,1-dimethylhexyl)- |
70435-92-6 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní prostředí) |
||
|
113. |
fenol, 4-(1,4-xxxxxxxxxxxxx)- |
164219-26-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) nařízení XXXXX – životní xxxxxxxxx) |
||
|
114. |
xxxxxxxxxxx, xxxxxxxxxxxx: xxxxx s lineárním x/xxxx rozvětveným xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 8 xxxxxx xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx na xxxxxxxxx xxxxxx, ethoxylované, xxxxxxxxxx xxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxxx z individuálních xxxxxxx xxxx jejich xxxxxxxxx |
xxxx(xxx-1,2-xxxxxxxxx), α-[(1,1,3,3-tetramethylbutyl)fenyl]-ω-hydroxy-; 2-(2-[4-(1,1,3,3-tetramethylbutyl)fenoxy]ethoxy)ethanol; polyethylenglykoloktylfenylether |
9036-19-5 |
vlastnosti vyvolávající xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
115. |
2-[4-(2,4,4-xxxxxxxxxxxxxxx-2-xx)xxxxxx]xxxxxxx; xxxx(xxx-1,2-xxxxxxxxx), α-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx]-ω-xxxxxxx-; xxxxxxxxxx, xxxxxxxxxxxx |
9002-93-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
|
116. |
20-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx; 3,6,9,12,15,18-xxxxxxxxxxxxxx-1-xx, 20-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2497-59-8 |
219-682-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
117. |
xxxxxxx, 2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2315-67-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx prostředí) |
||
|
118. |
ethanol, 2-[2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx]- |
2315-61-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
|
119. |
3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-(4-oktylfenoxy)- |
42173-90-0 |
255-695-5 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
|
120. |
xxxx(xxx-1,2-xxxxxxxxx), α-(oktylfenyl)-ω-hydroxy-, xxxxxxxxxx |
68987-90-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
121. |
xxxx(xxx-1,2-xxxxxxxxx), α-[4-(6-xxxxxxxxxxxx)xxxxx]-ω-xxxxxxx- |
59379-12-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
122. |
xxxxxxx, 2-(4-xxxxxxxxxxx)-; 2-(x-xxxxxxxxxxx)xxxxxxx |
51437-89-9 |
257-203-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
|
123. |
xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx- |
26636-32-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
124. |
xxxx(xxx-1,2-xxxxxxxxx), α-[4-(1-xxxxxxxxxxxx)xxxxx]-ω-xxxxxxx- |
73935-42-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
|
125. |
3,6,9,12,15,18-hexaoxaeikosan-1-ol, 20-(4-xxxxxxxxxxx)-; 20-(4-xxxxxxxxxxx)-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx |
32742-88-4 |
251-190-9 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
|
126. |
xxxxxxx, 2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]-; 2-(x-xxxxxxxxxxx)xxxxxxx |
51437-92-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
|
127. |
xxxxxxx, 2-[2-(4-oktylfenoxy)ethoxy]- |
51437-90-2 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
|
128. |
3,6,9,12,15-pentaoxaheptadekan-1-ol, 17-(4-xxxxxxxxxxx)- |
51437-94-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 písm. x) xxxxxxxx REACH – životní xxxxxxxxx) |
||
|
129. |
xxxx(xxx-1,2-xxxxxxxxx), α-(xxxxxxxxxxxxx)-ω-xxxxxxx- |
9004-87-9 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
130. |
2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxxx |
51437-91-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
131. |
3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx, 17-[4-(1,1,3,3-tetramethylbutyl)fenoxy]- |
2497-58-7 |
vlastnosti vyvolávající xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
|
132. |
xxxxxxx, 2-[2-[2-[4-(1,1,3,3-tetramethylbutyl)fenoxy]ethoxy]ethoxy]- |
2315-62-0 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx prostředí) |
||
|
133. |
ethanol, 2-[2-[2-[2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]xxxxxx]- |
2315-63-1 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
|
134. |
3,6,9,12-xxxxxxxxxxxxxxxxxx-1-xx, 14-[4-(1,1,3,3-tetramethylbutyl)fenoxy]- |
2315-64-2 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
135. |
3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2315-65-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
136. |
3,6,9,12,15,18,21,24,27-xxxxxxxxxxxxxxxx-1-xx, 29-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2315-66-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
137. |
xxxxxxx, 2-[3-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
1026254-24-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. f) xxxxxxxx REACH – xxxxxxx prostředí) |
||
|
138. |
ethanol, 2-[2-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
84658-53-7 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx prostředí) |
||
|
139. |
ethanol, 2-[2-(xxxxxxxxxxx)xxxxxx]- |
27176-92-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
|
140. |
X,X-xxxxxxxxxxxxxxxx |
X,X-xxxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxx; XXX |
68-12-2 |
200-679-5 |
xxxxxxx xxx xxxxxxxxxx kat. 1X |
|
141. |
xxxx-2-xxxxxx |
xxxxxxxxx; 2-xxxxxxxxxx |
79-06-1 |
201-173-7 |
xxxxxxxxxxxx xxx. 1X/ xxxxxxxxx xxx. 1X |
|
142. |
xxxxxxx, xxxxxxxxxxxxx, s obsahem ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7) |
68391-11-7 |
269-929-9 |
xxxxxxxxxxxx xxx. 1&xxxx;X/ xxxxxxxxx kat. 1X |
|
|
143. |
xxxxxxxx |
xxxxxxxx |
91-22-5 |
202-051-6 |
xxxxxxxxxxxx xxx. 1X |
|
144. |
xxxxxxxxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxxxxxxx; 2-xxxxxxxxxxxxx, xxxxxxxxxx- |
97-99-4 |
202-625-6 |
xxxxxxx xxx reprodukci xxx. 1B |
(1) Limit xxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxx v tabulce xxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxx 0,1 % (xxxxxxxxxxxx (xxxx.)), xxxx-xx x&xxxx;xxxx xxxxxxx xxxxxxx xxxxx.
(2)&xxxx;&xxxx;Xxxxx pro přijatelnou xxxxxxxxxx xxxx xxxxx xxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxx 0,01&xxxx;% (xxxxxxxxxxxx (hmot.)), xxx odpovídá xxxxxxxxxxxx xxxxxxxxxxxxxx limitu stanovenému x&xxxx;xxxxxxx VI xxxxxxxx (XX) č. 1272/2008.